Keren Leshem is a seasoned CEO and is currently the CEO of ViVac Pharma.  Keren is also an Executive Chairwoman at Sakura Bio, a board director at OCON Healthcare, Rambam Medtech, Ark Surgical and at the Swiss corp. Aspivix SA.  Previously, Keren was head of M&A at a European pharma company VISUfarma BV (headquartered in Amsterdam) and led their corporate development department with offices across Europe (Barcelona, Paris, Rome, London & Berlin). Prior to VISUfarma, Keren was the CEO of ViSci Ltd (License from NASDQ: AERI) & CEO of AOPharma (drug/device combination) where she successfully led pre-clinical, clinical, R&D and business development activities that included GMP manufacturing, CMC, regulatory & clinical operations in the US.  Keren has been with 8400 as a Mentor for the past 4 years and continues to support entrepreneurs and founders on their journey in MedTech & BioTech.